Innovating Works
G2B-002: GATE2BRAIN TOWARDS SME DESIGNATION AND PAEDIATRIC INVESTIGATIONAL PLAN GATE2BRAIN SL tramitó un HORIZON EUROPE: HORIZON-EIE-2022-SCALEUP-02 Gate2Brain (G2B) is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the bloo...
2023-07-20 - 2024-07-31 | Financiado
Gate2Brain: Gate2Brain. Medicines beyond barriers. GATE2BRAIN SL tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 In 2019, 30 million people worldwide were diagnosed with some form of CNS disorder and most of them lack effective treatment. This is largel...
2023-03-16 - 2025-03-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.